88 related articles for article (PubMed ID: 23462143)
1. Treatment with 5-azacytidin upregulates the expression of CD20 in CD20-negative B cell acute lymphoblastic leukemia: a case report.
Rahmé R; Benayoun E; Pautas C; Cordonnier C; Wagner-Ballon O; Maury S
Exp Hematol; 2013 Jun; 41(6):505-7. PubMed ID: 23462143
[No Abstract] [Full Text] [Related]
2. Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.
Huck K; Laws HJ; Meisel R; Traeger A; Bernbeck B; Schonberger S; Stackelberg VA; Pape H; Dilloo D
Haematologica; 2006 May; 91(5 Suppl):ECR07. PubMed ID: 16709515
[TBL] [Abstract][Full Text] [Related]
3. Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia.
Claviez A; Eckert C; Seeger K; Schrauder A; Schrappe M; Henze G; von Stackelberg A
Haematologica; 2006 Feb; 91(2):272-3. PubMed ID: 16461321
[TBL] [Abstract][Full Text] [Related]
4. CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.
Dworzak MN; Schumich A; Printz D; Pötschger U; Husak Z; Attarbaschi A; Basso G; Gaipa G; Ratei R; Mann G; Gadner H
Blood; 2008 Nov; 112(10):3982-8. PubMed ID: 18780832
[TBL] [Abstract][Full Text] [Related]
5. Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescue.
Hohloch K; Sahlmann CO; Lakhani VJ; Wulf G; Glass B; Hasenkamp J; Meller J; Riggert J; Trümper L; Griesinger F
Ann Hematol; 2011 Nov; 90(11):1307-15. PubMed ID: 21360108
[TBL] [Abstract][Full Text] [Related]
6. Early relapse after rituximab chemoimmunotherapy.
Kiss F; Buslig J; Szegedi I; Scholtz B; Kappelmayer J; Kiss C
Pediatr Blood Cancer; 2008 Feb; 50(2):372-5. PubMed ID: 17973316
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
[TBL] [Abstract][Full Text] [Related]
8. HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells.
Shimizu R; Kikuchi J; Wada T; Ozawa K; Kano Y; Furukawa Y
Leukemia; 2010 Oct; 24(10):1760-8. PubMed ID: 20686505
[TBL] [Abstract][Full Text] [Related]
9. Atypical presentations of Sweet's syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors.
Alencar C; Abramowtiz M; Parekh S; Braunshweig I; Jacobson M; Silverman L; Verma A
Am J Hematol; 2009 Oct; 84(10):688-9. PubMed ID: 19722261
[No Abstract] [Full Text] [Related]
10. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
11. Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
Maeshima AM; Taniguchi H; Fukuhara S; Morikawa N; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
Am J Surg Pathol; 2013 Apr; 37(4):563-70. PubMed ID: 23426122
[TBL] [Abstract][Full Text] [Related]
12. 5-Azacytidine partially restores CD20 expression in follicular lymphoma that lost CD20 expression after rituximab treatment: a case report.
Tsutsumi Y; Ohigashi H; Ito S; Shiratori S; Teshima T
J Med Case Rep; 2016 Feb; 10():27. PubMed ID: 26838941
[TBL] [Abstract][Full Text] [Related]
13. Itraconazole-enhanced vindesine neurotoxicity in adult acute lymphoblastic leukaemia.
Chen S; Wu D; Sun A; Qiu H; Jin Z; Tang X; Miao M; Fu Z; Ma X; Han Y; Hu X
Am J Hematol; 2007 Oct; 82(10):942. PubMed ID: 17617780
[No Abstract] [Full Text] [Related]
14. Role of allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemia.
Mattison RJ; Larson RA
Curr Opin Oncol; 2009 Nov; 21(6):601-8. PubMed ID: 19713843
[TBL] [Abstract][Full Text] [Related]
15. Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study Group.
Stryckmans P; De Witte T; Marie JP; Fillet G; Peetermans M; Bury J; Muus P; Andrien JM; Hayat M; Jaksic B
Leukemia; 1992; 6 Suppl 2():199-203. PubMed ID: 1578934
[No Abstract] [Full Text] [Related]
16. Escape mechanisms from antibody therapy to lymphoma cells: downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation.
Sugimoto T; Tomita A; Hiraga J; Shimada K; Kiyoi H; Kinoshita T; Naoe T
Biochem Biophys Res Commun; 2009 Dec; 390(1):48-53. PubMed ID: 19769942
[TBL] [Abstract][Full Text] [Related]
17. Therapy of acute lymphoblastic leukemia in adults.
Hoelzer D
Leukemia; 1992; 6 Suppl 2():132-5. PubMed ID: 1578915
[No Abstract] [Full Text] [Related]
18. Recurrent aleukemic leukemia cutis in a patient with pre-B-cell acute lymphoblastic leukemia.
Ansell LH; Mehta J; Cotliar J
J Clin Oncol; 2013 Jul; 31(20):e353-5. PubMed ID: 23733764
[No Abstract] [Full Text] [Related]
19. [Autotransplantation in acute leukemia using totipotent cells mobilized with filgrastim].
Ruiz-Argüelles GJ; Ruiz-Argüelles A; Alemán-Hoey DD; Arizpe Bravo D; Martin-López A; Ocejo Rodríguez A
Rev Invest Clin; 1993; 45(5):479-80. PubMed ID: 7510900
[No Abstract] [Full Text] [Related]
20. Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311.
Szatrowski TP; Dodge RK; Reynolds C; Westbrook CA; Frankel SR; Sklar J; Stewart CC; Hurd DD; Kolitz JE; Velez-Garcia E; Stone RM; Bloomfield CD; Schiffer CA; Larson RA
Cancer; 2003 Mar; 97(6):1471-80. PubMed ID: 12627512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
